Statement from The Multiple Myeloma Research Foundation (MMRF) on Distinguished Business Leader Richard Parsons
December 27, 2024
View
Sarclisa (isatuximab): A New Option for Patients With Newly Diagnosed Myeloma Not Eligible for Transplant
December 23, 2024
With Plethora Of New Myeloma Treatments, MMRF Study Aims To Better Guide Use
December 19, 2024
MMRF Patient Navigator Q&A: Nursing Insights From the NCCN and JADPRO Annual Meetings
December 18, 2024
Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments
Multiple Myeloma Research Foundation Partners with Family Reach to Deliver Critical Financial Support to Multiple Myeloma Patients and their Families
December 11, 2024
MMRF ASH 2024 Blog: Day 3
December 10, 2024
MMRF ASH 2024 Blog: Day 2
MMRF ASH 2024 Blog: Day 1
December 8, 2024
Multiple Myeloma Research Foundation (MMRF) Programs Power New Insights into High-Risk Multiple Myeloma at the 66th American Society of Hematology Annual Meeting
December 6, 2024
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 4, 2024
MM Clinical Advances From IMS 2024
November 15, 2024
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
Get Your Free Toolkit
